An Etiopathological Study Of Klaibya wsr to Impotence and Its Therapeutic Study (Upshayatmak parikshana) With Gokshuradi Churna
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Relief in sign and symptoms of Klaibya
研究概览
简要总结
under this clinical study minimum 40 patients of Klaibya will be treated with Gokshuradi churna. The constituents of this drug are Gokshura, Shatavari, Kshuraka, Kapikacchu, Nagabala and Atibala. This churna is described in classical text Chakradutta in the chapter of Vrishyadhikara. The action of this drug is Vrishya which improves the Shukra dosha. According to Charak Klaibya is originated from Shukradosha so due to improvement in Shukradosha by different actions of Shukrashrutikara, Shukravriddhikara and Vrishya. It is a nervine tonic which increases Sexual vigor and stamina by increasing strength of body and mind. Due to properties like Madhura rasa, guru, snigddha guna, Sheeta virya and Vrishya action improve the erectile dysfunftion. Kapikacchu improves the sperm count by enhancing spermatogenesis.
Kshuraka churna with milk provides strength to the nervous system. Nagabala and Kapikacchu have Shukral properties. Shatavari is also a Shukra Vridhikar.
The period of trial will be one month with 7 days follow up. dose will be 5gm twice daily orally with milk. patients will be selected from OPD and IPD and Diagnosed on the basis of sign and symptoms and necessary laboratory investigation. assessment will be done and conclusion will be drawn after completion of study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 21.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- Male
入选标准
- •Adult male patients suffering from Klaibya or Impotence.
- •Male patients suffering from infertility due to impotence.
排除标准
- •Female patients.
- •Patients suffering with diseases other than Klaibya.
- •Patients having mechanical cause of Klaibya like antisperm antibodies condition, obstruction or surgical process.
- •Other chronic diseases like STDs.
结局指标
主要结局
Relief in sign and symptoms of Klaibya
时间窗: 30 days
次要结局
- Improve quality of life of patients suffering from Klaibya(45 days)